Dyne Therapeutics, Inc.
DYN
$13.49
$0.917.23%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -60.28% | -42.63% | -34.54% | -41.51% | -36.08% |
| Total Depreciation and Amortization | 17.21% | 8.62% | 0.00% | -3.16% | -1.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.43% | 3.81% | 116.51% | 113.11% | 111.04% |
| Change in Net Operating Assets | 670.98% | 595.36% | -174.09% | 87.45% | 138.81% |
| Cash from Operations | -64.17% | -45.47% | -55.38% | -33.29% | -25.48% |
| Capital Expenditure | -82.65% | -358.84% | -225.93% | -18.61% | 31.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 80.67% | 84.04% | -340.00% | -307.03% | -209.63% |
| Cash from Investing | 79.03% | 81.57% | -344.96% | -312.00% | -212.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -79.10% | 25.09% | 1,390.92% | 782.49% | 766.93% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -66.58% | 25.09% | 1,390.92% | 782.49% | 766.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -127.96% | 121.21% | 720.39% | 2,847.34% | 1,291.43% |